Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study
Flavio Ewerton, Francisco Cruz, M Kapp, Stefan Klein, Petra Roehm, Christopher R. Chapple
Topics & Concepts
MedicineOveractive bladderPlaceboUrologyLower urinary tract symptomsInternal medicineAlternative medicineProstateCancerPathologyUrinary Bladder and Prostate ResearchPelvic floor disorders treatmentsBladder and Urothelial Cancer Treatments